NovaBay Pharmaceuticals (NBY) Insider Trading & Ownership $0.58 +0.01 (+1.72%) As of 04/25/2025 03:58 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock NovaBay Pharmaceuticals (NYSE:NBY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$188,977.78Number OfInsiders Selling(Last 12 Months)0 Get NBY Insider Trade Alerts Want to know when executives and insiders are buying or selling NovaBay Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NBY Insider Buying and Selling by Quarter NovaBay Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/8/2025Poplar Point Capital PartnersMajor ShareholderBuy300$0.47$141.00 4/4/2025Poplar Point Capital PartnersMajor ShareholderBuy4,538$0.52$2,359.76 4/2/2025Poplar Point Capital PartnersMajor ShareholderBuy917$0.58$531.86 3/31/2025Poplar Point Capital PartnersMajor ShareholderBuy21,654$0.59$12,775.86 3/28/2025Poplar Point Capital PartnersMajor ShareholderBuy49,400$0.61$30,134.00 3/26/2025Poplar Point Capital PartnersMajor ShareholderBuy13,292$0.61$8,108.12 3/24/2025Poplar Point Capital PartnersMajor ShareholderBuy100$0.60$60.00 3/20/2025Poplar Point Capital PartnersMajor ShareholderBuy5,320$0.61$3,245.20 3/18/2025Poplar Point Capital PartnersMajor ShareholderBuy14,000$0.63$8,820.00 3/14/2025Poplar Point Capital PartnersMajor ShareholderBuy25,511$0.63$16,071.93 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/12/2025Poplar Point Capital PartnersMajor ShareholderBuy11,837$0.62$7,338.94 3/10/2025Poplar Point Capital PartnersMajor ShareholderBuy14,645$0.58$8,494.10 3/7/2025Poplar Point Capital PartnersMajor ShareholderBuy102$0.55$56.10 3/4/2025Poplar Point Capital PartnersMajor ShareholderBuy4,000$0.58$2,320.00 2/27/2025Poplar Point Capital PartnersMajor ShareholderBuy385$0.61$234.85 2/25/2025Poplar Point Capital PartnersMajor ShareholderBuy25,033$0.62$15,520.46 2/20/2025Poplar Point Capital PartnersMajor ShareholderBuy1,836$0.63$1,156.68 2/18/2025Poplar Point Capital PartnersMajor ShareholderBuy3,222$0.66$2,126.52 2/3/2025Poplar Point Capital PartnersMajor ShareholderBuy2,597$0.64$1,662.08 1/31/2025Poplar Point Capital PartnersMajor ShareholderBuy70,685$0.65$45,945.25 1/27/2025Poplar Point Capital PartnersMajor ShareholderBuy31,703$0.69$21,875.07 (Data available from 1/1/2013 forward) NBY Insider Trading Activity - Frequently Asked Questions Who is on NovaBay Pharmaceuticals's Insider Roster? The list of insiders at NovaBay Pharmaceuticals includes Poplar Point Capital Partners. Learn more on insiders at NBY. What percentage of NovaBay Pharmaceuticals stock is owned by insiders? 0.10% of NovaBay Pharmaceuticals stock is owned by insiders. Learn more on NBY's insider holdings. Which NovaBay Pharmaceuticals insiders have been buying company stock? The following insider purchased NBY shares in the last 24 months: Poplar Point Capital Partners ($188,977.78). How much insider buying is happening at NovaBay Pharmaceuticals? Insiders have purchased a total of 301,077 NBY shares in the last 24 months for a total of $188,977.78 bought. NovaBay Pharmaceuticals Key ExecutivesMr. Justin M. Hall Esq. (Age 46)President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director Compensation: $364.15kMr. Tommy Law (Age 39)Controller, Interim CFO & Treasurer Compensation: $155.48k More Insider Trading Tools from MarketBeat Related Companies COCP Insider Selling PHIO Insider Selling INAB Insider Selling CLRB Insider Selling ME Insider Selling MBRX Insider Selling UPXI Insider Selling IMNN Insider Selling MRKR Insider Selling MEIP Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NYSE:NBY) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDeepSeek’s Clear and Present DangerDeepSeek — the alleged “$5.5 million” AI project — isn’t an open-source breakthrough. It’s a Trojan horse.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovaBay Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NovaBay Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
